Germany: The GBA's planned work programme for 2022
Following the German federal election in 2021, the G-BA announced in February this year its planned work programme for 2022. In this update, Maddy Dawson and Yasmina Zegaoui, summarise the key changes that will affect the assessment and pricing of medicines in Germany and the impact these changes will have on the pharmaceutical industry.
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
Contact us
Lightning Health can support you to navigate these complexities and to ensure robust value demonstration across healthcare systems. Contact us to discuss how we can support your European launch and patient access strategy.
Article published 20 April 2022.
